GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 203 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $8,589,000 | -48.4% | 177,016 | -44.1% | 1.59% | -56.2% |
| Q2 2019 | $16,654,000 | -20.4% | 316,619 | -19.9% | 3.62% | -16.1% |
| Q1 2019 | $20,924,000 | -13.7% | 395,309 | -33.1% | 4.32% | +35.5% |
| Q4 2018 | $24,257,000 | +325.6% | 590,909 | +293.9% | 3.19% | +280.1% |
| Q3 2018 | $5,700,000 | +57.4% | 150,000 | +87.3% | 0.84% | +47.2% |
| Q2 2018 | $3,621,000 | – | 80,100 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 355,509 | $17,171,000 | 9.58% |
| Perceptive Advisors | 4,989,066 | $240,971,000 | 6.75% |
| GREAT POINT PARTNERS LLC | 736,631 | $35,579,000,000 | 5.28% |
| Casdin Capital, LLC | 600,000 | $28,980,000 | 5.10% |
| Avoro Capital Advisors LLC | 1,765,548 | $85,276,000 | 4.07% |
| Iguana Healthcare Management, LLC | 115,000 | $5,555,000 | 3.65% |
| Camber Capital Management LP | 1,200,000 | $57,960,000 | 2.85% |
| NEXTHERA CAPITAL LP | 315,147 | $15,222,000 | 2.51% |
| RTW INVESTMENTS, LP | 456,921 | $22,069,000 | 2.10% |
| EMORY UNIVERSITY | 41,610 | $2,010,000 | 1.44% |